The stock market indices had a very mixed, sloppy session, and finished the day on a sour note, with the S&P 500 unchanged today. The day started out with a move down, a very strong rally in the morning ensured, reaching a new all-time high on the 5050 Nasdaq 100. The S&P 500 couldn’t get back to Friday’s double-top high at 22.82, reaching 2279 today, and then rolled over to 2269. The Dow closed down, the S&P 500 closed flat, while the Nasdaq 100 closed slightly in the plus column.

Net on the day, the Dow was down 32.16 at 19,855.22, 100 points off the high. The S&P 500 was up .01 at 2268.91, 11 points off the high and 4 points off the low. The Nasdaq 100 was up 10.27 at 5035.17, 14 points off the high.

Advance-declines were 18 to 11 positive on the New York Stock Exchange, and 9 to 5 positive the Nasdaq. Up/down volume was 4 to 3 positive on New York, total volume of 3.5 billion shares traded. The Nasdaq traded 1.7 billion shares and had a 10 to 7 positive volume ratio.

TheTechTrader.com board was mixed. Priceline.com (PCLN) was up 5.61 to 1535.25, Apple Inc. (AAPL) up 12 cents 119.11, but Alphabet Inc. (GOOG) dropped 1.86 to 804.79, Amazon.com, Inc. (AMZN) gave back 1.02 to 795.90, and Netflix, Inc. (NFLX) closed down 1.06 to 129.89.

Baidu, Inc. (BIDU) gained 3.15 to 180.31, Facebook, Inc. (FB) fell 55 cents to 124.35, and First Solar, Inc. (FSLR) closed negative by 18 cents to 33.39.

Tesla Motors, Inc. (TSLA) lost 1.41 to 229.87.

Other stocks to the upside included CoLucid Pharmaceuticals, Inc. (CLCD), up 1.55 to 35.00, Exelixis, Inc. (EXEL) up 1.33 to 18.91, U.S. Concrete, Inc. (USCR) 1.15 to 61.00, and United States Steel Corp. (X) 1.89 to 35.50.

On the downside, there were very fractional losers on our board today.

Checking TheTechTrader.com percent-gain leaderboard, Biocept, Inc. (BIOC) climbed 79 cents, or 77 1/2%, to 1.81, on 21.7 million shares traded.

ImmunoCellular Therapeutics, Ltd. (IMUC), after announcing management changes, popped 2.02, or 93%, to 4.20, on 1.4 million shares traded. GenVec, Inc. (GNVC) gained 3.82, or 77%, to 8.79, on 17 million shares traded.

Signal Genetics, Inc. (SGNL), on merger talks, exploded 12.69, or 265%, to 17.48, on 1.2 million shares traded.

Small biotech stocks and thinly-traded stocks were flying high today, and that’s not a good sign for the market, in my opinion. That said, they had an incredible day today, and the list of biotech stocks that did well today is many.

Stepping back and reviewing the hourly chart patterns, after opening lower, and rallying sharply in the morning, the indices backed off in the afternoon and closed lower on the Dow, flat on the S&P 500, and up a little on the Nasdaq 100.

It was a quiet, mixed session, and consolidation day, if nothing else.

Good Trading!

Harry

For more of Harry Boxer, sign up for a FREE 7-Day Trial to his Real-Time Technical Trading Diary.

(c) 2016 AdviceTrade, Inc. All rights reserved. Distributed only by written permission of AdviceTrade and The Technical Trader at info@advicetrade.com . In using any portion of Harry Boxer's content, you agree to the terms and conditions governing the use of the service as described in our disclaimer at http://www.thetechtrader.com

Mr. Boxer's commentaries and index analysis represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Trades mentioned on the site are hypothetical, not actual, positions.

Harry Boxer Archive

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.